User login
Article Type
Changed
Thu, 12/06/2018 - 20:20
Display Headline
When Rheumatoid Arthritis Biologics Fail
Rheumatoid arthritis patients who fail on a first-time trial of tumor necrosis factor inhibitor therapy should change to a biologic with a different mechanism of action, explains Dr. Daniel E. Furst.
Topics
Rheumatoid arthritis patients who fail on a first-time trial of tumor necrosis factor inhibitor therapy should change to a biologic with a different mechanism of action, explains Dr. Daniel E. Furst.
Rheumatoid arthritis patients who fail on a first-time trial of tumor necrosis factor inhibitor therapy should change to a biologic with a different mechanism of action, explains Dr. Daniel E. Furst.
Topics
Article Type
Display Headline
When Rheumatoid Arthritis Biologics Fail
Display Headline
When Rheumatoid Arthritis Biologics Fail
Article Source
PURLs Copyright
Inside the Article